For More Information:

LAW For More Information: Kimberly Goolsby (949) 464-0187 Kimberly@GoolsbyGroup.com FOR IMMEDIATE RELEASE FDA APPROVES REFRACTECs® CKSM (Conductive KeratoplastySM) NON-LASER PROCEDURE FOR FARSIGHTEDNESS CK Uses Radiofrequency Energy, Instead of a Laser, to Reshape the Cornea Without lancinating or Removing Tissue IRVINE, Calif., April 16, 2002 Ophthalmic device manufacturer Refractec Inc. now announced that the U.S. Food and Drug Administration has approved CK (Conductive Keratoplasty), a procedure for farsightedness (hyperopia) in people over stipulation 40.

CK utilizes the controlled release of radiofrequency (RF) energy, instead of a laser or scalpel, to circumscribe the cornea. The minimally invasive CK procedure takes less than three proceedings and is done in-office with only topical (eye drop) anesthesia. Farsightedness, which occurs when the cornea is too flat or the eye is too short, is the most common vision indent in America and affects more than 60 million ...If you entreat to get a full essay, order it on our website: OrderEssay.net

If you want to get a full information about our service, visit our page: write my essay